Evidence map›Paper›PMID 32641730›Full record

ArticleNature communications2020

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.

Alberto L Garcia-Basteiro, Gemma Moncunill, Marta Tortajada, Marta Vidal, Caterina Guinovart, Alfons Jiménez, Rebeca Santano, Sergi Sanz, Susana Méndez, Anna Llupià and 28 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04635592 (Serological Diagnostics of COVID-19 and Risk Factors for Infection Among Different Groups of Health Care Workers at Surgical Division at Tertiary Hospital), which is not on this map. Cited by 236 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
236citing papers in PubMed, 11 pooled it
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04635592 unknown statusnot on this map

Serological Diagnostics of COVID-19 and Risk Factors for Infection Among Different Groups of Health Care Workers at Surgical Division at Tertiary Hospital

TypeobservationalSponsorUniversity Medical Centre LjubljanaRan2020 to 2021Enrolled300ConditionsSARS-CoV InfectionArmsSARS-CoV2 nasal swab
3 · Its place in the literature

Who cites it

236 citing papers in PubMed, 11 syntheses or guidelines pooled it, 427 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Systematic review of productivity loss among healthcare workers due to Covid-19.The International journal of health planning and management · 2022
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

176 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 4 institutions in 2 countries.

Alberto L Garcia-Basteiro *ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. alberto.garcia-basteiro@isglobal.org.ORCID http://orcid.org/0000-0002-2038-5505
Gemma Moncunill *ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-5105-9836
Marta TortajadaOccupational Health Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Marta VidalISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Caterina GuinovartISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Alfons JiménezISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Rebeca SantanoISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0007-5315
Sergi SanzISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-5010-4527
Susana MéndezISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Anna LlupiàISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8284-7560
Ruth AguilarISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-3277-3107
Selena AlonsoISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4029-9716
Diana BarriosISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Carlo CarolisCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4240-1139
Pau CisteróISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Eugenia ChólizFaculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.
Angeline CruzISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4217-9654
Silvia FochsISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Chenjerai JairoceISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Jochen HechtCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Montserrat LamogliaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5283-4563
Mikel J MartínezISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Robert A MitchellISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Natalia OrtegaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Nuria PeyISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Laura PuyolISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Marta RibesISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Neus RosellISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Patricia SotomayorISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Sara TorresISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Sarah WilliamsISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Sonia BarrosoOccupational Health Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Anna VilellaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2329-676X
José MuñozISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Antoni TrillaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6869-0242
Pilar VarelaOccupational Health Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Alfredo MayorISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Carlota DobañoISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6751-4060
Barcelona Institute for Global Health · ESUniversitat de Barcelona · ESManhiça Health Research Centre · MZCentre for Genomic Regulation · ES

Funding

NIAID NIH HHS HHSN272201400008C
6 · The paper itself

Abstract

Health care workers (HCW) are a high-risk population to acquire SARS-CoV-2 infection from patients or other fellow HCW. This study aims at estimating the seroprevalence against SARS-CoV-2 in a random sample of HCW from a large hospital in Spain. Of the 578 participants recruited from 28 March to 9 April 2020, 54 (9.3%, 95% CI: 7.1-12.0) were seropositive for IgM and/or IgG and/or IgA against SARS-CoV-2. The cumulative prevalence of SARS-CoV-2 infection (presence of antibodies or past or current positive rRT-PCR) was 11.2% (65/578, 95% CI: 8.8-14.1). Among those with evidence of past or current infection, 40.0% (26/65) had not been previously diagnosed with COVID-19. Here we report a relatively low seroprevalence of antibodies among HCW at the peak of the COVID-19 epidemic in Spain. A large proportion of HCW with past or present infection had not been previously diagnosed with COVID-19, which calls for active periodic rRT-PCR testing in hospital settings.

Indexed as

Health PersonnelAdultAntibodies, ViralAsymptomatic InfectionsBetacoronavirusCoronavirus InfectionsCOVID-19FemaleHumansMaleMiddle AgedOccupational HealthPandemicsPneumonia, ViralRisk FactorsRNA, ViralAntibodies, ViralRNA, Viral

Identifiers

PMID32641730
PMCPMC7343863
OpenAlexW3042194934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.